Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Andrographolide, the main bioactive compound in Andrographis paniculata, has been studied for its immunomodulatory and anti-inflammatory properties. Several preclinical studies (in vitro and animal models) suggest that andrographolide can modulate immune system activity by downregulating pro-inflammatory cytokines (such as TNF-α, IL-6, and IL-1β) and inhibiting NF-κB signaling pathways. These effects have prompted interest in its potential role in managing autoimmune conditions, where immune dysregulation and inflammation are central features.

Some animal studies have shown benefits in models of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. For example, andrographolide was found to reduce disease severity and inflammatory markers in rodent models of arthritis. However, robust clinical trials in humans with autoimmune disorders are lacking. A handful of small human studies and anecdotal reports suggest possible benefit, but these are not sufficient to draw firm conclusions. Systematic reviews emphasize the need for larger, high-quality clinical trials to confirm efficacy and safety in autoimmune patients.

In summary, while there is a scientific rationale and promising preclinical evidence for andrographolide’s use in autoimmune disorders, current human data is limited and preliminary. Thus, its use is not yet considered evidence-based or standard of care in autoimmune disease management.

More about Andrographolide
More about Autoimmune Disorders

Other ingredients used for Autoimmune Disorders

Other health conditions supported by Andrographolide

Products containing Andrographolide